Bile Duct Cancer (Cholangiocarcinoma) Market To Observe Strong Development By 2017

Overview

Bile duct cancer or cholangiocarcinoma are tumors that occur in the bile duct. Symptoms include discomfort in the tummy area (abdomen), loss of appetite, high temperatures (fevers) and weight loss. Treatment includes chemotherapy and radiation therapy.

Click here for sample report @ http://www.wiseguyreports.com/sample-request/2740077-bile-duct-cancer-cholangiocarcinoma-pipeline-review-h2-2017

Report Highlights

The Pharmaceutical and Healthcare latest pipeline guide Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Bile Duct Cancer (Cholangiocarcinoma) (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Bile Duct Cancer (Cholangiocarcinoma) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Bile Duct Cancer (Cholangiocarcinoma) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 4, 54, 25, 1, 17 and 2 respectively. Similarly, the Universities portfolio in Phase II, Phase I and Preclinical stages comprises 1, 1 and 4 molecules, respectively.

 Major Scope of the report:

- The pipeline guide provides a snapshot of the global therapeutic landscape of Bile Duct Cancer (Cholangiocarcinoma) (Oncology). 
- The pipeline guide reviews pipeline therapeutics for Bile Duct Cancer (Cholangiocarcinoma) (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources. 
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. 
- The pipeline guide reviews key companies involved in Bile Duct Cancer (Cholangiocarcinoma) (Oncology) therapeutics and enlists all their major and minor projects. 

Table of Contents 

Table of Contents 2 
Introduction 5 
Bile Duct Cancer (Cholangiocarcinoma) - Overview 6 
Bile Duct Cancer (Cholangiocarcinoma) - Therapeutics Development 7 
Bile Duct Cancer (Cholangiocarcinoma) - Therapeutics Assessment 23 
Bile Duct Cancer (Cholangiocarcinoma) - Companies Involved in Therapeutics Development 37 
Bile Duct Cancer (Cholangiocarcinoma) - Drug Profiles 71 
Bile Duct Cancer (Cholangiocarcinoma) - Dormant Projects 738 
Bile Duct Cancer (Cholangiocarcinoma) - Discontinued Products 740 
Bile Duct Cancer (Cholangiocarcinoma) - Product Development Milestones 741 
Appendix 753

List of Tables 
Number of Products under Development for Bile Duct Cancer (Cholangiocarcinoma), H2 2017 
Number of Products under Development by Companies, H2 2017 
Number of Products under Development by Universities/Institutes, H2 2017 
Products under Development by Companies, H2 2017 
Products under Development by Universities/Institutes, H2 2017 
Number of Products by Stage and Target, H2 2017 
Number of Products by Stage and Mechanism of Action, H2 2017 
Number of Products by Stage and Route of Administration, H2 2017 

 .Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2740077-bile-duct-cancer-cholangiocarcinoma-pipeline-review-h2-2017

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.